S&P 500   2,989.69 (-0.20%)
DOW   27,001.98 (-0.08%)
QQQ   193.04 (-0.25%)
AAPL   234.37 (-0.40%)
FB   189.55 (+0.35%)
AMZN   1,777.43 (+0.57%)
GE   8.91 (+0.11%)
TSLA   259.75 (+0.72%)
ACB   3.59 (-4.52%)
NFLX   286.28 (+0.71%)
BAC   30.18 (+1.51%)
S&P 500   2,989.69 (-0.20%)
DOW   27,001.98 (-0.08%)
QQQ   193.04 (-0.25%)
AAPL   234.37 (-0.40%)
FB   189.55 (+0.35%)
AMZN   1,777.43 (+0.57%)
GE   8.91 (+0.11%)
TSLA   259.75 (+0.72%)
ACB   3.59 (-4.52%)
NFLX   286.28 (+0.71%)
BAC   30.18 (+1.51%)
Log in

Portola Pharmaceuticals News Headlines (NASDAQ:PTLA)

$27.44
+0.02 (+0.07 %)
(As of 10/16/2019 04:00 PM ET)
Today's Range
$26.92
Now: $27.45
$27.70
50-Day Range
$25.93
MA: $28.34
$31.02
52-Week Range
$14.81
Now: $27.45
$37.95
Volume308,697 shs
Average Volume810,742 shs
Market Capitalization$1.88 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.09

Headlines

Portola Pharmaceuticals (NASDAQ PTLA) News Headlines

Source:
DateHeadline
Portola Pharmaceuticals to Announce Third Quarter 2019 Financial Results on Tuesday, November 5, 2019Portola Pharmaceuticals to Announce Third Quarter 2019 Financial Results on Tuesday, November 5, 2019
finance.yahoo.com - October 15 at 1:30 PM
Portola Pharmaceuticals Inc (NASDAQ:PTLA) Given Consensus Rating of "Hold" by AnalystsPortola Pharmaceuticals Inc (NASDAQ:PTLA) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - October 14 at 2:01 PM
Citigroup Trims Portola Pharmaceuticals (NASDAQ:PTLA) Target Price to $44.00Citigroup Trims Portola Pharmaceuticals (NASDAQ:PTLA) Target Price to $44.00
www.americanbankingnews.com - October 9 at 11:45 AM
$35.20 Million in Sales Expected for Portola Pharmaceuticals Inc (NASDAQ:PTLA) This Quarter$35.20 Million in Sales Expected for Portola Pharmaceuticals Inc (NASDAQ:PTLA) This Quarter
www.americanbankingnews.com - October 3 at 9:36 AM
-$0.87 EPS Expected for Portola Pharmaceuticals Inc (NASDAQ:PTLA) This Quarter-$0.87 EPS Expected for Portola Pharmaceuticals Inc (NASDAQ:PTLA) This Quarter
www.americanbankingnews.com - October 1 at 11:49 AM
Portola Pharmaceuticals Appoints Ted W. Love, M.D., to its Board of DirectorsPortola Pharmaceuticals Appoints Ted W. Love, M.D., to its Board of Directors
finance.yahoo.com - September 19 at 9:47 AM
Heres Why Portola Pharmaceuticals (NASDAQ:PTLA) Can Afford Some DebtHere's Why Portola Pharmaceuticals (NASDAQ:PTLA) Can Afford Some Debt
finance.yahoo.com - August 16 at 7:31 PM
Here's Why Portola Pharmaceuticals (NASDAQ:PTLA) Can Afford Some DebtHere's Why Portola Pharmaceuticals (NASDAQ:PTLA) Can Afford Some Debt
finance.yahoo.com - August 16 at 7:31 PM
Portola prices stock offering at $28; shares down 4% premarketPortola prices stock offering at $28; shares down 4% premarket
seekingalpha.com - August 14 at 7:23 AM
Portola Dives on New Stock OfferingPortola Dives on New Stock Offering
www.baystreet.ca - August 13 at 7:52 PM
Portola Pharmaceuticals Announces Pricing of Public Offering of Common StockPortola Pharmaceuticals Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - August 13 at 7:52 PM
The Daily Biotech Pulse: Jazz Goes Shopping, Portola Offering, Novelion Delays Quarterly ResultsThe Daily Biotech Pulse: Jazz Goes Shopping, Portola Offering, Novelion Delays Quarterly Results
www.benzinga.com - August 13 at 8:51 AM
Portola -4.8% alongside $200M share offeringPortola -4.8% alongside $200M share offering
seekingalpha.com - August 13 at 12:22 AM
Why Portola Pharmaceuticals Is Rocketing 10.9% Higher TodayWhy Portola Pharmaceuticals Is Rocketing 10.9% Higher Today
finance.yahoo.com - August 8 at 7:52 PM
Portola Pharmaceuticals, Inc. (PTLA) CEO Scott Garland on Q2 2019 Results - Earnings Call TranscriptPortola Pharmaceuticals, Inc. (PTLA) CEO Scott Garland on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 8 at 6:44 AM
Portola Pharmaceuticals Inc (PTLA) Q2 2019 Earnings Call TranscriptPortola Pharmaceuticals Inc (PTLA) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 8 at 6:44 AM
Edited Transcript of PTLA earnings conference call or presentation 7-Aug-19 8:30pm GMTEdited Transcript of PTLA earnings conference call or presentation 7-Aug-19 8:30pm GMT
finance.yahoo.com - August 8 at 6:44 AM
Portola Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate UpdatePortola Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - August 7 at 7:47 PM
Portola Pharmaceuticals (PTLA) Reports Q2 Loss, Tops Revenue EstimatesPortola Pharmaceuticals (PTLA) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - August 7 at 7:47 PM
Portola Pharmaceuticals Q2 2019 Earnings PreviewPortola Pharmaceuticals Q2 2019 Earnings Preview
seekingalpha.com - August 6 at 7:46 PM
Portola Launches European Sales of Ondexxya® (Andexanet Alfa) with First Orders in EuropePortola Launches European Sales of Ondexxya® (Andexanet Alfa) with First Orders in Europe
finance.yahoo.com - August 6 at 7:46 PM
Zoetis (ZTS) Beats on Earnings in Q2, Lifts 2019 GuidanceZoetis (ZTS) Beats on Earnings in Q2, Lifts 2019 Guidance
finance.yahoo.com - August 6 at 7:46 PM
U.S. Centers for Medicare and Medicaid Services (CMS) Increases New Technology Add-On Payment (NTAP) Reimbursement for Portola Pharmaceuticals AndexxaU.S. Centers for Medicare and Medicaid Services (CMS) Increases New Technology Add-On Payment (NTAP) Reimbursement for Portola Pharmaceuticals' Andexxa
finance.yahoo.com - August 5 at 7:26 AM
Portola Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for PTLAPortola Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for PTLA
www.nasdaq.com - July 30 at 7:29 PM
Portola Pharmaceuticals to Announce Second Quarter 2019 Financial Results on Wednesday, August 7, 2019Portola Pharmaceuticals to Announce Second Quarter 2019 Financial Results on Wednesday, August 7, 2019
finance.yahoo.com - July 17 at 9:15 AM
Interesting PTLA Put Options For July 19thInteresting PTLA Put Options For July 19th
www.nasdaq.com - July 11 at 5:43 PM
Regardless Of Your View On Portola Pharmaceuticals, There Is Money In Their OptionsRegardless Of Your View On Portola Pharmaceuticals, There Is Money In Their Options
seekingalpha.com - July 9 at 9:04 AM
Portola Pharmaceuticals Presents New In Vitro Data Demonstrating that Four-Factor Prothrombin Complex Concentrates (4F-PCCs) Had No Direct Effect on Inhibition of Thrombin Generation by Factor Xa InhibitorsPortola Pharmaceuticals Presents New In Vitro Data Demonstrating that Four-Factor Prothrombin Complex Concentrates (4F-PCCs) Had No Direct Effect on Inhibition of Thrombin Generation by Factor Xa Inhibitors
finance.yahoo.com - July 8 at 9:02 AM
Portola Pharmaceuticals (PTLA) Shares Cross Above 200 DMAPortola Pharmaceuticals (PTLA) Shares Cross Above 200 DMA
www.nasdaq.com - June 28 at 5:52 PM
Portola Presents New Interim Data on its Oral SYK/JAK Inhibitor Cerdulatinib in Heavily Pre-Treated Patients with Relapsed/Refractory Follicular LymphomaPortola Presents New Interim Data on its Oral SYK/JAK Inhibitor Cerdulatinib in Heavily Pre-Treated Patients with Relapsed/Refractory Follicular Lymphoma
finance.yahoo.com - June 19 at 6:59 PM
Portola Pharmaceuticals: Headaches For Us, Buying Opportunity For InvestorsPortola Pharmaceuticals: Headaches For Us, Buying Opportunity For Investors
seekingalpha.com - June 7 at 4:51 PM
How Is Portola’s Andexxa Placed in the First Quarter?How Is Portola’s Andexxa Placed in the First Quarter?
finance.yahoo.com - May 24 at 9:11 AM
What’s Portola’s Growth Strategy for Fiscal 2019?What’s Portola’s Growth Strategy for Fiscal 2019?
finance.yahoo.com - May 24 at 9:11 AM
Portola Pharmaceuticals Announces New Analysis from the ANNEXA-4 Study of its Factor Xa InhibitorPortola Pharmaceuticals Announces New Analysis from the ANNEXA-4 Study of its Factor Xa Inhibitor
www.nasdaq.com - May 22 at 6:44 PM
Portola Pharmaceuticals Announces New Analysis from the ANNEXA-4 Study of its Factor Xa Inhibitor Reversal Agent Andexxa® in Patients with Spontaneous (Non-Traumatic) Intracranial HemorrhagePortola Pharmaceuticals Announces New Analysis from the ANNEXA-4 Study of its Factor Xa Inhibitor Reversal Agent Andexxa® in Patients with Spontaneous (Non-Traumatic) Intracranial Hemorrhage
finance.yahoo.com - May 22 at 6:44 PM
Portola Pharmaceuticals Enters Oversold Territory (PTLA)Portola Pharmaceuticals Enters Oversold Territory (PTLA)
www.nasdaq.com - May 17 at 7:12 PM
Peeking Back In On Portola PharmaceuticalsPeeking Back In On Portola Pharmaceuticals
seekingalpha.com - May 13 at 9:06 AM
Noteworthy Wednesday Option Activity: MYL, WYNN, PTLANoteworthy Wednesday Option Activity: MYL, WYNN, PTLA
www.nasdaq.com - May 9 at 9:04 AM
3 Key Takeaways From Portola Pharmaceuticals Quarterly Results3 Key Takeaways From Portola Pharmaceuticals' Quarterly Results
www.fool.com - May 9 at 9:04 AM
Edited Transcript of PTLA earnings conference call or presentation 8-May-19 12:30pm GMTEdited Transcript of PTLA earnings conference call or presentation 8-May-19 12:30pm GMT
finance.yahoo.com - May 9 at 9:04 AM
3 Key Takeaways From Portola Pharmaceuticals' Quarterly Results3 Key Takeaways From Portola Pharmaceuticals' Quarterly Results
finance.yahoo.com - May 9 at 9:04 AM
Portola Pharmaceuticals (PTLA) CEO Scott Garland on Q1 2019 Results - Earnings Call TranscriptPortola Pharmaceuticals' (PTLA) CEO Scott Garland on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 8 at 7:03 PM
Portola Pharmaceuticals (PTLA) Reports Q1 Loss, Tops Revenue EstimatesPortola Pharmaceuticals (PTLA) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 8 at 7:03 PM
Why Portola Pharmaceuticals Is Tumbling 14.5% TodayWhy Portola Pharmaceuticals Is Tumbling 14.5% Today
finance.yahoo.com - May 8 at 7:03 PM
Portola Pharmaceuticals Inc (PTLA) Q1 2019 Earnings Call TranscriptPortola Pharmaceuticals Inc (PTLA) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 8 at 7:03 PM
Portola Pharmaceuticals beats by $0.09, beats on revenuePortola Pharmaceuticals beats by $0.09, beats on revenue
seekingalpha.com - May 8 at 9:04 AM
Portola Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate UpdatePortola Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update
www.globenewswire.com - May 8 at 9:04 AM
Portola Pharma down 6% despite Q1 non-GAAP EPS and revenue beatPortola Pharma down 6% despite Q1 non-GAAP EPS and revenue beat
seekingalpha.com - May 8 at 9:04 AM
Portola Pharmaceuticals Q1 2019 Earnings PreviewPortola Pharmaceuticals Q1 2019 Earnings Preview
seekingalpha.com - May 7 at 6:26 PM
Portola Pharmaceuticals (PTLA) May Report Negative Earnings: Know the Trend Ahead of Next Weeks ReleasePortola Pharmaceuticals (PTLA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - May 2 at 9:08 AM
This page was last updated on 10/16/2019 by MarketBeat.com Staff

Featured Article: FAANG Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel